One aspect of the IPO I didn’t cover in the prior post is this: Why do Talecris’ investors want to cash out now?
Maybe it’s because they recognize that the advent of transgenics will render drugs derived from plasma fractionation obsolete. The quote from Bruce Carter of ZGEN in #msg-17114738 is apropos here.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.